Search
Resmed Inc
RMDAdd to Watchlist
191.890USD
0.0000.00%
Close 07-23 16:00（ET）Quotes delayed by 15 min
27.83BMarket Cap
18.43P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Resmed Inc is 7.18, ranking 153 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 300.00, with a high of 335.00 and a low of 225.00.
Analyst Rating
Based on
21
analysts
Hold
Current Rating
247.967
Target Price
+26.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Resmed Inc
RMD
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Resmed Inc's expected revenue for the next quarter?
Resmed Inc's expected revenue is 1.46B.
What is Resmed Inc's price target?
Analysts forecast that Resmed Inc's price target is USD 300.00, with the highest forecast at USD 335.00 and the lowest forecast at USD 225.00.
How have Resmed IncRMD's recent earnings per share performed?
The market expectation was USD 2.74, while Resmed IncRMD's earnings per share (EPS) for the previous quarter was USD 2.69. EPS for the next quarter is expected at USD 2.89.
What is the analyst rating for Resmed Inc?
Based on the ratings of Resmed Inc's stock from 21 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.